Bell's Palsy cases following administration of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System (VAERS)

Journal of Vaccines and Vaccination

Volumn 3, Issue 2, 2012, Pages

  Cano, Maria V ^a   Lewis, Paige ^a   Ou, Alan C ^b   Sharma, Devindra ^a   Vellozzi, Claudia ^a   Broder, Karen R ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879818683     PISSN: None     EISSN: 21577560     Source Type: Journal    
DOI: 10.4172/2157-7560.1000134     Document Type: Review

References (37)

1. National Center for Immunization and Respiratory Diseases, CDC, Centers for Disease Control and Prevention (CDC) (2009) Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 58: 1-8.
2. Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, et al. (2009) Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 58: 1-52.
3. Salmon DA, Akhtar A, Mergler MJ, Vannice KS, Izurieta H, et al. (2011) Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program. Pediatrics 127: S78-S86.
4. Vellozzi C, Broder KR, Haber P, Guh A, Nguyen M, et al. (2010) Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. Vaccine 28: 7248-7255.
5. Mutsch M, Zhou W, Rhodes P, Bopp M, Chen RT, et al. (2004) Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 350: 896-903.
6. Zhou W, Pool V, Destefano F, Iskander JK, Haber P, et al. (2004) A potential signal of Bell's palsy after parenteral inactivated influenza vaccine: reports to the Vaccine Adverse Event Reporting System (VAERS)-United States, 1991-2001. Pharmacoepidemiol Drug Saf 13: 505-510.
7. Varricchio F, Iskander J, Destefano F, Ball R, Pless R, et al. (2004) Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 23: 287-294.
8. Medical Dictionary for Regulatory Activities.
9. Food and Drug Administration. (2005) 21 CFR Part 600.80. Postmarketing reporting of adverse experiences. Federal Register 70 FR 148982.
10. United States Census 2010.
11. Centers for Disease Control and Prevention (CDC) (2010) Interim results: state-specific influenza A (H1N1) 2009 monovalent vaccination coverage-United States, October 2009-January 2010. MMWR Morb Mortal Wkly Rep 59: 363-368.
12. Centers for Disease Control and Prevention (CDC) (2010) Interim results: state-specific seasonal influenza vaccination coverage-United States, August 2009-January 2010. MMWR Morb Mortal Wkly Rep 59: 477-484.
13. Tiemstra JD, Khatkhate N (2007) Bell's palsy: Diagnosis and management. Am Fam Physician 76: 997-1002.
14. Shmorgun D, Chan WS, Ray JC (2002) Association between Bell's palsy in pregnancy and pre-eclampsia. QJM 95: 359-362.
15. Shapiro JL, Yudin MH, Ray JG (1999) Bell's palsy and tinnitus during pregnancy: predictors of pre-eclampsia? Three cases and a detailed review of the literature. Acta Otolaryngol 119: 647-651.
16. Morris AM, Deeks SL, Hill MD, Midroni G, Goldstein WC, et al. (2002) Annualized incidence and spectrum of illness from an outbreak investigation of Bell's palsy. Neuroepidemiology 21: 255-261.
17. Stowe J, Andrews N, Wise L, Miller E (2006) Bell's palsy and parenteral inactivated influenza vaccine. Hum Vaccin 2: 110-112.
18. Gilden DH (2004) Clinical practice. Bell's palsy. N Engl J Med 351: 1323-1331.
19. De Diego JI, Prim MP, Madero R, Gavilan J (1999) Seasonal patterns of idiopathic facial paralysis: a 16-year study. Otolaryngol Head Neck Surg 120: 269-271.
20. Peitersen E (1982) The natural history of Bell's palsy. Am J Otol 4: 107-111.
21. Rath B, Linder T, Cornblath D, Hudson M, Fernandopulle R, et al. (2007) All that palsies is not Bell's-the need to define Bell's palsy as an adverse event following immunization. Vaccine 26: 1-14.
22. Centers for Disease Control and Prevention (2010) Final estimates for 2009-10 seasonal influenza and influenza A (H1N1) 2009 Monovalent Vaccination Coverage-United States, August 2009 through May, 2010.
23. Rowlands S, Hooper R, Hughes R, Burney P (2002) The epidemiology and treatment of Bell's palsy in the UK. Eur J Neurol 9: 63-67.
24. Peitersen E (2002) Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl 4-30.
25. Chou CH, Liou WP, Hu KI, Loh CH, Chou CC, et al. (2007) Bell's palsy associated with influenza vaccination: two case reports. Vaccine 25: 2839-2841.
26. Piercy J (2005) Bell's palsy. BMJ 330: 1374.
27. Bosco D, Plastino M, Bosco F, Consoli A, Labate A, et al. (2011) Bell's palsy: a manifestation of prediabetes? Acta Neurol Scand 123: 68-72.
28. Vrabec JT, Isaacson B, Van Hook JW (2007) Bell's palsy and pregnancy. Otolaryngol Head Neck Surg 137: 858-861.
29. Moro PL, Broder K, Zheteyeva Y, Walton K, Rohan P, et al. (2011) Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009. Am J Obstet Gynecol 204: 146. e1-7.
30. Moro PL, Broder K, Zheteyeva Y, Revzina N, Tepper N, et al. (2011) Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol 205: 473. e1-9.
31. Black S, Eskola J, Siegrist CA, Halsey N, Macdonald N, et al. (2009) Importance of background rates of disease in assessment of vaccine safety during mass immunization with pandemic H1N1 influenza vaccines. Lancet 374: 2115-2122.
32. Vellozzi C, Burwen DR, Dobardzic A, Ball R, Walton K, et al. (2009) Safety of trivalent inactivated influenza vaccines in adults: Background for pandemic influenza vaccine safety monitoring. Vaccine 27: 2114-2120.
33. Couch RB (2004) Nasal vaccination, Escherichia coli enterotoxin, and Bell's palsy. New Engl J Med 350: 860-861.
34. Lewis D, Huo Z, Barnett S, Kromann I, Giemza R, et al. (2009) Transient facial nerve paralysis (Bell's palsy) following intranasal develivery of a genetically detoxified mutant of Escherichia coli heat labile toxin. PLoS One 4: e6999.
35. Izurieta HS, Haber P, Wise RP, Iskander J, Pratt D, et al. (2005) Adverse events reported following live, cold-adapted, intranasal influenza vaccine. JAMA 294: 2720-2725.
36. Lee GM, Greene SK, Weintraub ES, Baggs J, Kulldorff M, et al. (2011) H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project. Am J Prev Med 41: 121-128.
37. IOM (Institute of Medicine) (2011) Adverse effects of vaccines: Evidence and Causality. The National Academies Press, Washington DC, USA.